FDA head calls for investigation into approval of controversial Alzheimer’s drug
01:16
In a letter, FDA Commissioner Janet Woodcock wrote that she’s concerned about “contacts between representatives from Biogen and FDA during the review process, including some that may have occurred outside of the formal correspondence process.”July 9, 2021
UP NEXT
Tennessee law restricting drag performances goes into effect at midnight
02:30
Long-Covid patients find hope in treatment aiming to restore taste and smell
02:15
Trump’s rivals and allies react to historic indictment
02:19
Storm systems in South and Midwest putting 58 million under tornado threats
03:54
NYPD prepares for Trump indictment protests
02:26
What’s next for Trump after his historic indictment?